First human study of a new drug for advanced solid tumors
Part of Cancer clinical trials.
This study tests a new experimental drug called KH815 for people with advanced solid tumors that haven't responded to standard treatments. The goal is to see if the drug is safe and how well it works against different types of cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old.
- You must have a solid tumor (a lump or mass) that has continued to grow even after standard treatments, or for which no standard treatment exists.
- You must be well enough to be up and around (able to do light activities, like walking).
- You must be able to have your tumor measured with CT or MRI scans.
- You must not have had cancer treatment like chemotherapy or radiation within a few weeks before starting the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called KH801, which may help the immune system fight cancer. It's for people whose cancer has spread or can't be removed and who have already tried other treatments without success. The goal is to see if the drug is safe and if it helps slow down the cancer.
This Phase 1 trial tests KH617, a new treatment, in adults with advanced cancers to see if it can be given safely and whether it shows signs of benefit. It is especially focused on tumors that have few or no standard treatment options, including certain brain tumor recurrences.
This trial tests a new drug called HSK39775 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective for people who have few other options.
This Phase 1 trial studies how a new medicine (KC1036) works and how safe it is for people with advanced solid cancers that have grown despite standard treatments. It may help future patients by showing whether the drug can control cancer in difficult-to-treat cases.
This Phase 1 study tests SHR-A2102, a new cancer medicine, in adults with advanced solid tumors. It mainly looks at safety and how the body handles the drug, and it may help if standard treatments are not working or are not an option.
This study tests an investigational medicine called KHN922 for advanced or unresectable solid tumors that haven't responded to other treatments. The goal is to see if it is safe and how well it works.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.